Hendrik Scholl

Company: Belite Bio

Job title: Chief Medical Officer

Seminars:

Unlocking the Potential of Non-Invasive Oral Therapies to Improve Patient Compliance and Overcome the Limitations of Intravitreal Delivery 2:00 pm

Assessing preclinical and clinical evidence supporting reducing vitamin A delivery to the eye as a therapeutic strategy to slow geographic atrophy progression Exploring Stargardt disease as a juvenile macular degeneration disease model or geographic atrophy Exploring opportunities for earlier treatment targeting intermediate AMDRead more

day: Day1